Literature DB >> 15133342

Long-term deterioration of lung function in asthmatic outpatients.

Maciej Kupczyk1, Izabela Kupryś, Paweł Górski, Piotr Kuna.   

Abstract

BACKGROUND: Although the long-term deterioration of lung function in asthmatic patients has been described, the exact mechanism remains to be determined.
OBJECTIVES: The aim of this study was to find correlations between age, sex, atopic status, duration of asthma, asthma severity and the decline in pulmonary function.
METHOD: The medical histories of 1,006 randomly chosen asthmatic outpatients were studied and retrospective data on asthma duration, spirometry results, treatment and symptomatology were gathered. A screening spirometry was performed.
RESULTS: 598 women and 408 men (age: 44.59, range 12-95 years) participated in the study. Intermittent asthma was diagnosed in 35.4%, chronic mild asthma in 33.4%, moderate asthma in 23.8% and severe asthma in 7.45% of the patients. Statistically significant correlations between patient age, asthma duration and lung function measurements were found. Linear regression revealed the following differences in lung functions per year of asthma duration: FEV1: -0.882% of predicted; FVC: -0.509% of predicted; FEV1/FVC: -0.324% of predicted. The unadjusted annual decline was 80.1 ml/year (p = 0.00003) in FEV1 and 20.5 ml/year (p = 0.036) in FVC. A multiple regression model revealed that asthma severity appears to be the strongest factor influencing pulmonary function (beta = -0.55, p < 0.001 for FEV1). Also, significant associations between pulmonary function measurements, patient age, atopic status and male sex were noted.
CONCLUSIONS: The results of this large cohort study show that asthmatic patients develop a progressive decline in pulmonary function correlated with age, sex, duration of asthma and asthma severity. Early diagnosis and intervention is necessary to ameliorate any potential negative impact of asthma on lung function. Copyright 2004 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2004        PMID: 15133342     DOI: 10.1159/000077420

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  4 in total

1.  Guidelines for diagnosis and management of bronchial asthma: Joint ICS/NCCP (I) recommendations.

Authors:  Ritesh Agarwal; Sahajal Dhooria; Ashutosh Nath Aggarwal; Venkata N Maturu; Inderpaul S Sehgal; Valliappan Muthu; Kuruswamy T Prasad; Lakshmikant B Yenge; Navneet Singh; Digambar Behera; Surinder K Jindal; Dheeraj Gupta; Thanagakunam Balamugesh; Ashish Bhalla; Dhruva Chaudhry; Sunil K Chhabra; Ramesh Chokhani; Vishal Chopra; Devendra S Dadhwal; George D'Souza; Mandeep Garg; Shailendra N Gaur; Bharat Gopal; Aloke G Ghoshal; Randeep Guleria; Krishna B Gupta; Indranil Haldar; Sanjay Jain; Nirmal K Jain; Vikram K Jain; Ashok K Janmeja; Surya Kant; Surender Kashyap; Gopi C Khilnani; Jai Kishan; Raj Kumar; Parvaiz A Koul; Ashok Mahashur; Amit K Mandal; Samir Malhotra; Sabir Mohammed; Prasanta R Mohapatra; Dharmesh Patel; Rajendra Prasad; Pallab Ray; Jai K Samaria; Potsangbam Sarat Singh; Honey Sawhney; Nusrat Shafiq; Navneet Sharma; Updesh Pal S Sidhu; Rupak Singla; Jagdish C Suri; Deepak Talwar; Subhash Varma
Journal:  Lung India       Date:  2015-04

2.  A Review of Portable Electronic Spirometers: Implications for Asthma Self-Management.

Authors:  Delesha M Carpenter; Reina Jurdi; Courtney A Roberts; Michelle Hernandez; Robert Horne; Amy Chan
Journal:  Curr Allergy Asthma Rep       Date:  2018-08-25       Impact factor: 4.806

3.  Expression of FOXP3 and GATA3 Transcription Factors Among Bronchial Asthmatics in Northern Population.

Authors:  Rashmi Pandey; Ved Prakash
Journal:  Indian J Clin Biochem       Date:  2019-10-21

4.  The efficacy of allergen immunotherapy with cat dander in reducing symptoms in clinical practice.

Authors:  Aerik A Williams; John R Cohn; Shirley M Fung; Patricia Padams
Journal:  Biomed Res Int       Date:  2013-07-31       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.